NK cell-T cell interactions

Natural Killer Cells

Volumn , Issue , 2010, Pages 297-308

  Chambers, Benedict J ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884770372     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-370454-2.00022-3     Document Type: Chapter

References (154)

1. Agaugue S., Marcenaro E., Ferranti B., Moretta L., Moretta A. Human natural killer cells exposed to IL-2, IL-12, IL-18, or IL-4 differently modulate priming of naive T cells by monocyte-derived dendritic cells. Blood 2008, 112:1776-1783.
2. Aktas E., Akdis M., Bilgic S., Disch R., Falk C.S., Blaser K., Akdis C., Deniz G. Different natural killer (NK) receptor expression and immunoglobulin E (IgE) regulation by NK1 and NK2 cells. Clin Exp Immunol 2005, 140:301-309.
3. Ashkar A.A., Reid S., Verdu E.F., Zhang K., Coombes B.K. Interleukin-15 and NK1.1+ cells provide innate protection against acute Salmonella enterica serovar Typhimurium infection in the gut and in systemic tissues. Infect Immun 2009, 77:214-222.
4. Assarsson E., Kambayashi T., Schatzle J.D., Cramer S.O., von Bonin A., Jensen P.E., Ljunggren H.G., Chambers B.J. NK cells stimulate proliferation of T and NK cells through 2B4/CD48 interactions. J Immunol 2004, 173:174-180.
5. Assarsson E., Kambayashi T., Persson C.M., Ljunggren H.G., Chambers B.J. 2B4 co-stimulation: NK cells and their control of adaptive immune responses. Mol Immunol 2005, 42:419-423.
6. Azuma M., Yssel H., Phillips J.H., Spits H., Lanier L.L. Functional expression of B7/BB1 on activated T lymphocytes. J Exp Med 1993, 177:845-850.
7. BajenoffM., Breart B., Huang A.Y., Qi H., Cazareth J., Braud V.M., Germain R.N., Glaichenhaus N. Natural killer cell behavior in lymph nodes revealed by static and real-time imaging. J Exp Med 2006, 203:619-631.
8. Barao I., Hanash A.M., Hallett W., Welniak L.A., Sun K., Redelman D., Blazar B.R., Levy R.B., Murphy W.J. Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells. Proc Natl Acad Sci USA 2006, 103:5460-5465.
9. Bellone G., Aste-Amezaga M., Trinchieri G., Rodeck U. Regulation of NK cell functions by TGF-beta 1. J Immunol 1995, 155:1066-1073.
10. Biron C.A., Nguyen K.B., Pien G.C., Cousens L.P., Salazar-Mather T.P. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 1999, 17:189-220.
11. Blasius A.L., Barchet W., Cella M., Colonna M. Development and function of murine B220+CD11c+NK1.1+ cells identify them as a subset of NK cells. J Exp Med 2007, 204:2561-2568.
12. Brady J., Hayakawa Y., Smyth M.J., Nutt S.L. IL-21 induces the functional maturation of murine NK cells. J Immunol 2004, 172:2048-2058.
13. Brooks C.F., Moore M. Presentation of a soluble bacterial antigen and cell-surface alloantigens by large granular lymphocytes (LGL) in comparison with monocytes. Immunology 1986, 58:343-350.
14. Bryceson Y.T., Long E.O. Line of attack: NK cell specificity and integration of signals. Curr Opin Immunol 2008, 20:344-352.
15. Buentke E., Heffler L.C., Wilson J.L., Wallin R.P., Lofman C., Chambers B.J., Ljunggren H.G., Scheynius A. Natural killer and dendritic cell contact in lesional atopic dermatitis skin-Malassezia-influenced cell interaction. J Invest Dermatol 2002, 119:850-857.
16. Butte M.J., Keir M.E., Phamduy T.B., Sharpe A.H., Freeman G.J. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity 2007, 27:111-122.
17. Butte M.J., Pena-Cruz V., Kim M.J., Freeman G.J., Sharpe A.H. Interaction of human PD-L1 and B7-1. Mol Immunol 2008, 45:3567-3572.
18. Byrne P., McGuirk P., Todryk S., Mills K.H. Depletion of NK cells results in disseminating lethal infection with Bordetella pertussis associated with a reduction of antigen-specific Th1 and enhancement of Th2, but not Tr1 cells. Eur J Immunol 2004, 34:2579-2588.
19. Cai G., Kastelein R.A., Hunter C.A. IL-10 enhances NK cell proliferation, cytotoxicity and production of IFN-gamma when combined with IL-18. Eur J Immunol 1999, 29:2565-2658.
20. Caminschi I., Ahmet F., Heger K., Brady J., Nutt S.L., Vremec D., Pietersz S., Lahoud M.H., Schofield L., Hansen D.S., O'Keeffe M., Smyth M.J., Bedoui S., Davey G.M., Villadangos J.A., Heath W.R., Shortman K. Putative IKDCs are functionally and developmentally similar to natural killer cells, but not to dendritic cells. J Exp Med 2007, 204:2579-2590.
21. Carbone E., Terrazzano G., Ruggiero G., Zanzi D., Ottaiano A., Manzo C., Karre K., Zappacosta S. Recognition of autologous dendritic cells by human NK cells. Eur J Immunol 1999, 29:4022-4029.
22. Castriconi R., Cantoni C., Della Chiesa M., Vitale M., Marcenaro E., Conte R., Biassoni R., Bottino C., Moretta L., Moretta A. Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells. Proc Natl Acad Sci U S A 2003, 100:4120-4125.
23. Cerboni C., Zingoni A., Cippitelli M., Piccoli M., Frati L., Santoni A. Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK-cell lysis. Blood 2007, 110:606-615.
24. Chambers B.J., Salcedo M., Ljunggren H.G. Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1). Immunity 1996, 5:311-317.
25. Chan C.W., Crafton E., Fan H.N., Flook J., Yoshimura K., Skarica M., Brockstedt D., Dubensky T.W., Stins M.F., Lanier L.L., Pardoll D.M., Housseau F. Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity. Nat Med 2006, 12:207-213.
26. Combe C.L., Curiel T.J., Moretto M.M., Khan I.A. NK cells help to induce CD8(+)-T-cell immunity against Toxoplasma gondii in the absence of CD4(+) T cells. Infect Immun 2005, 73:4913-4921.
27. Cooper M.A., Fehniger T.A., Turner S.C., Chen K.S., Ghaheri B.A., Ghayur T., Carson W.E., Caligiuri M.A. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood 2001, 97:3146-3151.
28. D'Orazio J.A., Stein-Streilein J. Human natural killer (NK) cells present staphylococcal enterotoxin B (SEB) to T lymphocytes. Clin Exp Immunol 1996, 104:366-373.
29. Dasgupta S., Bhattacharya-Chatterjee M., O'Malley B.W., Chatterjee S.K. Inhibition of NK cell activity through TGF-beta 1 by down-regulation of NKG2D in a murine model of head and neck cancer. J Immunol 2005, 175:5541-5550.
30. Degli-Esposti M.A., Smyth M.J. Close encounters of different kinds: dendritic cells and NK cells take centre stage. Nat Rev Immunol 2005, 5:112-124.
31. Della Chiesa M., Vitale M., Carlomagno S., Ferlazzo G., Moretta L., Moretta A. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. Eur J Immunol 2003, 33:1657-1666.
32. Deniz G., Akdis M., Aktas E., Blaser K., Akdis C.A. Human NK1 and NK2 subsets determined by purification of IFN-gamma-secreting and IFN-gamma-nonsecreting NK cells. Eur J Immunol 2002, 32:879-884.
33. Deniz G., Erten G., Kucuksezer U.C., Kocacik D., Karagiannidis C., Aktas E., Akdis C.A., Akdis M. Regulatory NK cells suppress antigen-specific T cell responses. J Immunol 2008, 180:850-857.
34. Dunn G.P., Old L.J., Schreiber R.D. The Three Es of Cancer Immunoediting. Annu Rev Immunol 2004, 22:329-360.
35. Eriksson M., Meadows S.K., Wira C.R., Sentman C.L. Unique phenotype of human uterine NK cells and their regulation by endogenous TGF-beta. J Leukoc Biol 2004, 76:667-675.
36. Fan Z., Yu P., Wang Y., Fu M.L., Liu W., Sun Y., Fu Y.X. NK-cell activation by LIGHT triggers tumor-specific CD8+ T-cell immunity to reject established tumors. Blood 2006, 107:1342-1351.
37. Fehniger T.A., Cooper M.A., Nuovo G.J., Cella M., Facchetti F., Colonna M., Caligiuri M.A. CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood 2003, 101:3052-3057.
38. Ferlazzo G., Thomas D., Lin S.L., Goodman K., Morandi B., Muller W.A., Moretta A., Munz C. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J Immunol 2004, 172:1455-1462.
39. Frederiksen K.S., Lundsgaard D., Freeman J.A., Hughes S.D., Holm T.L., Skrumsager B.K., Petri A., Hansen L.T., McArthur G.A., Davis I.D., Skak K. IL-21 induces in vivo immune activation of NK cells and CD8(+) T cells in patients with metastatic melanoma and renal cell carcinoma. Cancer Immunol Immunother 2008, 57:1439-1449.
40. Ghiringhelli F., Menard C., Martin F., Zitvogel L. The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression. Immunol Rev 2006, 214:229-238.
41. Gilbertson S.M., Shah P.D., Rowley D.A. NK cells suppress the generation of Lyt-2+ cytolytic T cells by suppressing or eliminating dendritic cells. J Immunol 1986, 136:3567-3571.
42. Giroux M., Yurchenko E., St-Pierre J., Piccirillo C.A., Perreault C. T regulatory cells control numbers of NK cells and CD8alpha+ immature dendritic cells in the lymph node paracortex. J Immunol 2007, 179:4492-4502.
43. Glas R., Franksson L., Une C., Eloranta M.L., Ohlen C., Orn A., Karre K. Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype. An adaptive component of NK cell-mediated responses. J Exp Med 2000, 191:129-138.
44. Godfrey I., MacDonald H.R., Kronenberg M., Smyth M.J., Van Kaer L. NKT cells: what's in a name?. Nat Rev Immunol 2004, 4:231-237.
45. Goodier M.R., Londei M. Lipopolysaccharide stimulates the proliferation of human CD56+CD3-NK cells: a regulatory role of monocytes and IL-10. J Immunol 2000, 165:139-147.
46. Gray J.D., Hirokawa M., Ohtsuka K., Horwitz D.A. Generation of an inhibitory circuit involving CD8+ T cells, IL-2, and NK cell-derived TGF-beta: contrasting effects of anti-CD2 and anti-CD3. J Immunol 1998, 160:2248-2254.
47. Greenwald R.J., Freeman G.J., Sharpe A.H. The B7 family revisited. Annu Rev Immunol 2005, 23:515-548.
48. Guerra N., Tan Y.X., Joncker N.T., Choy A., Gallardo F., Xiong N., Knoblaugh S., Cado D., Greenberg N.M., Raulet D.H. NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. Immunity 2008, 28:571-580.
49. Hanna J., Gonen-Gross T., Fitchett J., Rowe T., Daniels M., Arnon T.I., Gazit R., Joseph A., Schjetne K.W., Steinle A., Porgador A., Mevorach D., Goldman-Wohl D., Yagel S., LaBarre M.J., Buckner J.H., Mandelboim O. Novel APC-like properties of human NK cells directly regulate T cell activation. J Clin Invest 2004, 114:1612-1623.
50. Hayakawa Y., Smyth M.J. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J Immunol 2006, 176:1517-1524.
51. Hayakawa Y., Screpanti V., Yagita H., Grandien A., Ljunggren H.G., Smyth M.J., Chambers B.J. NK cell TRAIL eliminates immature dendritic cells in vivo and limits dendritic cell vaccination efficacy. J Immunol 2004, 172:123-129.
52. He K.M., Ma Y., Wang S., Min W.P., Zhong R., Jevnikar A., Zhang Z.X. Donor double-negative Treg promote allogeneic mixed chimerism and tolerance. Eur J Immunol 2007, 37:3455-3466.
53. Honorati M.C., Neri S., Cattini L., Facchini A. IL-17 enhances the susceptibility of U-2 OS osteosarcoma cells to NK cell lysis. Clin Exp Immunol 2003, 133:344-349.
54. Horwitz D.A., Gray J.D., Ohtsuka K. Role of NK cells and TGF-beta in the regulation of T-cell-dependent antibody production in health and autoimmune disease. Microbes Infect 1999, 1:1305-1311.
55. Hoshino T., Winkler-Pickett R.T., Mason A.T., Ortaldo J.R., Young H.A. IL-13 production by NK cells: IL-13-producing NK and T cells are present in vivo in the absence of IFN-gamma. J Immunol 1999, 162:51-59.
56. Huang D., Shi F.D., Jung S., Pien G.C., Wang J., Salazar-Mather T.P., He T.T., Weaver J.T., Ljunggren H.G., Biron C.A., Littman D.R., RansohoffR.M. The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system. FASEB J 2006, 20:896-905.
57. Hunter C.A., Subauste C.S., Van Cleave V.H., Remington J.S. Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha. Infect Immun 1994, 62:2818-2824.
58. Hunter C.A., Bermudez L., Beernink H., Waegell W., Remington J.S. Transforming growth factor-beta inhibits interleukin-12-induced production of interferon-gamma by natural killer cells: a role for transforming growth factor-beta in the regulation of T cell-independent resistance to Toxoplasma gondii. Eur J Immunol 1995, 25:994-1000.
59. Ivanov I.I., McKenzie B.S., Zhou L., Tadokoro C.E., Lepelley A., Lafaille J.J., Cua D.J., Littman D.R. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006, 126:1121-1133.
60. Jinushi M., Takehara T., Tatsumi T., Kanto T., Miyagi T., Suzuki T., Kanazawa Y., Hiramatsu N., Hayashi N. Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection. J Immunol 2004, 173:6072-6081.
61. Johansson S., Berg L., Hall H., Hoglund P. NK cells: elusive players in autoimmunity. Trends Immunol 2005, 26:613-618.
62. Kaplan M.H., Schindler U., Smiley S.T., Grusby M.J. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 1996, 4:313-319.
63. Kasaian M.T., Whitters M.J., Carter L.L., Lowe L.D., Jussif J.M., Deng B., Johnson K.A., Witek J.S., Senices M., Konz R.F., Wurster A.L., Donaldson D.D., Collins M., Young D.A., Grusby M.J. IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity. Immunity 2002, 16:559-569.
64. Katsumoto T., Kimura M., Yamashita M., Hosokawa H., Hashimoto K., Hasegawa A., Omori M., Miyamoto T., Taniguchi M., Nakayama T. STAT6-dependent differentiation and production of IL-5 and IL-13 in murine NK2 cells. J Immunol 2004, 173:4967-4975.
65. Kiessling R., Klein E., Wigzell H. "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol 1975, 5:112-117.
66. Korbel D.S., Finney O.C., Riley E.M. Natural killer cells and innate immunity to protozoan pathogens. Int J Parasitol 2004, 34:1517-1528.
67. Korsgren M., Persson C.G., Sundler F., Bjerke T., Hansson T., Chambers B.J., Hong S., Van Kaer L., Ljunggren H.G., Korsgren O. Natural killer cells determine development of allergen-induced eosinophilic airway inflammation in mice. J Exp Med 1999, 189:553-562.
68. Kos F.J., Engleman E.G. Role of natural killer cells in the generation of influenza virus-specific cytotoxic T cells. Cell Immunol 1996, 173:1-6.
69. Kundu N., Fulton A.M. Interleukin-10 inhibits tumor metastasis, downregulates MHC class I, and enhances NK lysis. Cell Immunol 1997, 180:55-61.
70. Laffont S., Seillet C., Ortaldo J., Coudert J.D., Guery J.C. Natural killer cells recruited into lymph nodes inhibit alloreactive T-cell activation through perforin-mediated killing of donor allogeneic dendritic cells. Blood 2008, 112:661-671.
71. Laouar Y., Sutterwala F.S., Gorelik L., Flavell R.A. Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma. Nat Immunol 2005, 6:600-607.
72. Lee K.M., Bhawan S., Majima T., Wei H., Nishimura M.I., Yagita H., Kumar V. Cutting edge: the NK cell receptor 2B4 augments antigen-specific T cell cytotoxicity through CD48 ligation on neighboring T cells. J Immunol 2003, 170:4881-4885.
73. Lee J.C., Lee K.M., Kim D.W., Heo D.S. Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients. J Immunol 2004, 172:7335-7340.
74. Lee K.M., McNerney M.E., Stepp S.E., Mathew P.A., Schatzle J.D., Bennett M., Kumar V. 2B4 acts as a non-major histocompatibility complex binding inhibitory receptor on mouse natural killer cells. J Exp Med 2004, 199:1245-1254.
75. Lee S.H., Miyagi T., Biron C.A. Keeping NK cells in highly regulated antiviral warfare. Trends Immunol 2007, 28:252-259.
76. Li M.O., Wan Y.Y., Sanjabi S., Robertson A.K., Flavell R.A. Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 2006, 24:99-146.
77. Lighvani A.A., Frucht D.M., Jankovic D., Yamane H., Aliberti J., Hissong B.D., Nguyen B.V., Gadina M., Sher A., Paul W.E., O'Shea J.J. T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells. Proc Natl Acad Sci U S A 2001, 98:15137-15142.
78. Liu R., Van Kaer L., La Cava A., Price M., Campagnolo I., Collins M., Young D.A., Vollmer T.L., Shi F.D. Autoreactive T cells mediate NK cell degeneration in autoimmune disease. J Immunol 2006, 176:5247-5254.
79. Lo C.K., Lam Q.L., Sun L., Wang S., Ko K.H., Xu H., Wu C.Y., Zheng B.J., Lu L. Natural killer cell degeneration exacerbates experimental arthritis in mice via enhanced interleukin-17 production. Arthritis Rheum 2008, 58:2700-2711.
80. Lodoen M.B., Lanier L.L. Natural killer cells as an initial defense against pathogens. Curr Opin Immunol 2006, 18:391-398.
81. Loza M.J., Perussia B. Final steps of natural killer cell maturation: a model for type 1-type 2 differentiation?. Nat Immunol 2001, 2:917-924.
82. Lu L., Ikizawa K., Hu D., Werneck M.B., Wucherpfennig K.W., Cantor H. Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway. Immunity 2007, 26:593-604.
83. Lugo-Villarino G., Maldonado-Lopez R., Possemato R., Penaranda C., Glimcher L.H. T-bet is required for optimal production of IFN-gamma and antigen-specific T cell activation by dendritic cells. Proc Natl Acad Sci U S A 2003, 100:7749-7754.
84. Ma H.L., Whitters M.J., Konz R.F., Senices M., Young D.A., Grusby M.J., Collins M., Dunussi-Joannopoulos K. IL-21 activates both innate and adaptive immunity to generate potent antitumor responses that require perforin but are independent of IFN-gamma. J Immunol 2003, 171:608-615.
85. Mailliard R.B., Son Y.I., Redlinger R., Coates P.T., Giermasz A., Morel P.A., Storkus W.J., Kalinski P. Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function. J Immunol 2003, 171:2366-2373.
86. Martin-Fontecha A., Thomsen L.L., Brett S., Gerard C., Lipp M., Lanzavecchia A., Sallusto F. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 2004, 5:1260-1265.
87. McNerney M.E., Guzior D., Kumar V. 2B4 (CD244)-CD48 interactions provide a novel MHC class I-independent system for NK-cell self-tolerance in mice. Blood 2005, 106:1337-1340.
88. Meadows S.K., Eriksson M., Barber A., Sentman C.L. Human NK cell IFN-gamma production is regulated by endogenous TGF-beta. Int Immunopharmacol 2006, 6:1020-1028.
89. Mehrotra P.T., Donnelly R.P., Wong S., Kanegane H., Geremew A., Mostowski H.S., Furuke K., Siegel J.P., Bloom E.T. Production of IL-10 by human natural killer cells stimulated with IL-2 and/or IL-12. J Immunol 1998, 160:2637-2644.
90. Mehta D.S., Wurster A.L., Grusby M.J. Biology of IL-21 and the IL-21 receptor. Immunol Rev 2004, 202:84-95.
91. Micallef M.J., Tanimoto T., Torigoe K., Nishida Y., Kohno K., Ikegami H., Kurimoto M. Simultaneous exposure to interleukin-18 and interleukin-10 in vitro synergistically augments murine spleen natural killer cell activity. Cancer Immunol Immunother 1999, 48:109-117.
92. Mocellin S., Panelli M., Wang E., Rossi C.R., Pilati P., Nitti D., Lise M., Marincola F.M. IL-10 stimulatory effects on human NK cells explored by gene profile analysis. Genes Immun 2004, 5:621-630.
93. Moore K.W., de Waal Malefyt R., Coffman R.L., O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001, 19:683-765.
94. Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., Coffman R.L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986, 136:2348-2357.
95. Mosmann T.R., Li L., Sad S. Functions of CD8 T-cell subsets secreting different cytokine patterns. Semin Immunol 1997, 9:87-92.
96. Patera A.C., Pesnicak L., Bertin J., Cohen J.I. Interleukin 17 modulates the immune response to vaccinia virus infection. Virology 2002, 299:56-63.
97. Peritt D., Robertson S., Gri G., Showe L., Aste-Amezaga M., Trinchieri G. Differentiation of human NK cells into NK1 and NK2 subsets. J Immunol 1998, 161:5821-5824.
98. Persson C.M., Assarsson E., Vahlne G., Brodin P., Chambers B.J. Critical role of Qa1b in the protection of mature dendritic cells from NK cell-mediated killing. Scand J Immunol 2008, 67:30-36.
99. Petersson M., Charo J., Salazar-Onfray F., Noffz G., Mohaupt M., Qin Z., Klein G., Blankenstein T., Kiessling R. Constitutive IL-10 production accounts for the high NK sensitivity, low MHC class I expression, and poor transporter associated with antigen processing (TAP)-1/2 function in the prototype NK target YAC-1. J Immunol 1998, 161:2099-2105.
100. Phillips J.H., Le A.M., Lanier L.L. Natural killer cells activated in a human mixed lymphocyte response culture identified by expression of Leu-11 and class II histocompatibility antigens. J Exp Med 1984, 159:993-1008.
101. Prlic M., Gibbs J., Jameson S.C. Characteristics of NK cell migration early after vaccinia infection. J Immunol 2005, 175:2152-2157.
102. Rabinovich B.A., Li J., Shannon J., Hurren R., Chalupny J., Cosman D., Miller R.G. Activated, but not resting, T cells can be recognized and killed by syngeneic NK cells. J Immunol 2003, 170:3572-3576.
103. Ralainirina N., Poli A., Michel T., Poos L., Andres E., Hentges F., Zimmer J. Control of NK cell functions by CD4+CD25+ regulatory T cells. J Leukoc Biol 2007, 81:144-153.
104. Robbins S.H., Bessou G., Cornillon A., Zucchini N., Rupp B., Ruzsics Z., Sacher T., Tomasello E., Vivier E., Koszinowski U.H., Dalod M. Natural killer cells promote early CD8 T cell responses against cytomegalovirus. PLoS Pathog 2007, 3:e123.
105. Roda J.M., Parihar R., Lehman A., Mani A., Tridandapani S., Carson W.E. Interleukin-21 enhances NK cell activation in response to antibody-coated targets. J Immunol 2006, 177:120-129.
106. Romagnani C., Della Chiesa M., Kohler S., Moewes B., Radbruch A., Moretta L., Moretta A., Thiel A. Activation of human NK cells by plasmacytoid dendritic cells and its modulation by CD4+ T helper cells and CD4+ CD25hi T regulatory cells. Eur J Immunol 2005, 35:2452-2458.
107. Roncarolo M.G., Bigler M., Haanen J.B., Yssel H., Bacchetta R., de Vries J.E., Spits H. Natural killer cell clones can efficiently process and present protein antigens. J Immunol 1991, 147:781-787.
108. Rook A.H., Kehrl J.H., Wakefield L.M., Roberts A.B., Sporn M.B., Burlington D.B., Lane H.C., Fauci A.S. Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. J Immunol 1986, 136:3916-3920.
109. Roy S., Barnes P.F., Garg A., Wu S., Cosman D., Vankayalapati R. NK cells lyse T regulatory cells that expand in response to an intracellular pathogen. J Immunol 2008, 180:1729-1736.
110. Ruggeri L., Capanni M., Urbani E., Perruccio K., Shlomchik W.D., Tosti A., Posati S., Rogaia D., Frassoni F., Aversa F., Martelli M.F., Velardi A. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002, 295:2097-2100.
111. Saito S., Nakashima A., Myojo-Higuma S., Shiozaki A. The balance between cytotoxic NK cells and regulatory NK cells in human pregnancy. J Reprod Immunol 2008, 77:14-22.
112. Samson S.I., Richard O., Tavian M., Ranson T., Vosshenrich C.A., Colucci F., Buer J., Grosveld F., Godin I., Di Santo J.P. GATA-3 promotes maturation, IFN-gamma production, and liver-specific homing of NK cells. Immunity 2003, 19:701-711.
113. Saudemont A., Jouy N., Hetuin D., Quesnel B. NK cells that are activated by CXCL10 can kill dormant tumor cells that resist CTL-mediated lysis and can express B7-H1 that stimulates T cells. Blood 2005, 105:2428-2435.
114. Scala G., Allavena P., Ortaldo J.R., Herberman R.B., Oppenheim J.J. Subsets of human large granular lymphocytes (LGL) exhibit accessory cell functions. J Immunol 1985, 134:3049-3055.
115. Scalzo A.A. Successful control of viruses by NK cells-a balance of opposing forces?. Trends Microbiol 2002, 10:470-474.
116. Scott M.J., Hoth J.J., Turina M., Woods D.R., Cheadle W.G. Interleukin-10 suppresses natural killer cell but not natural killer T cell activation during bacterial infection. Cytokine 2006, 33:79-86.
117. Seo S.K., Jeong H.Y., Park S.G., Lee S.W., Choi I.W., Chen L., Choi I. Blockade of endogenous B7-H1 suppresses antibacterial protection after primary Listeria monocytogenes infection. Immunology 2008, 123:90-99.
118. Shanker A., Verdeil G., Buferne M., Inderberg-Suso E.M., Puthier D., Joly F., Nguyen C., Leserman L., Auphan-Anezin N., Schmitt-Verhulst A.M. CD8 T cell help for innate antitumor immunity. J Immunol 2007, 179:6651-6662.
119. Shi F.D., Van Kaer L. Reciprocal regulation between natural killer cells and autoreactive T cells. Nat Rev Immunol 2006, 6:751-760.
120. Shibata Y., Foster L.A., Kurimoto M., Okamura H., Nakamura R.M., Kawajiri K., Justice J.P., Van Scott M.R., Myrvik Q.N., Metzger W.J. Immunoregulatory roles of IL-10 in innate immunity: IL-10 inhibits macrophage production of IFN-gamma-inducing factors but enhances NK cell production of IFN-gamma. J Immunol 1998, 161:4283-4288.
121. Shimizu K., Fujii S. DC therapy induces long-term NK reactivity to tumors via host DC. Eur J Immunol 2009, 39:457-468.
122. Simon A.K., Jones E., Richards H., Wright K., Betts G., Godkin A., Screaton G., Gallimore A. Regulatory T cells inhibit Fas ligand-induced innate and adaptive tumour immunity. Eur J Immunol 2007, 37:758-767.
123. Sivori S., Cantoni C., Parolini S., Marcenaro E., Conte R., Moretta L., Moretta A. IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors. Eur J Immunol 2003, 33:3439-3447.
124. Smyth M.J., Kelly J.M., Baxter A.G., Korner H., Sedgwick J.D. An essential role for tumor necrosis factor in natural killer cell-mediated tumor rejection in the peritoneum. J Exp Med 1998, 188:1611-1619.
125. Smyth M.J., Crowe N.Y., Hayakawa Y., Takeda K., Yagita H., Godfrey I. NKT cells - conductors of tumor immunity?. Curr Opin Immunol 2002, 14:165-171.
126. Smyth M.J., Teng M.W., Swann J., Kyparissoudis K., Godfrey I., Hayakawa Y. CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer. J Immunol 2006, 176:1582-1587.
127. Strowig T., Brilot F., Munz C. Noncytotoxic functions of NK cells: direct pathogen restriction and assistance to adaptive immunity. J Immunol 2008, 180:7785-7791.
128. Su H.C., Ishikawa R., Biron C.A. Transforming growth factor-beta expression and natural killer cell responses during virus infection of normal, nude, and SCID mice. J Immunol 1993, 151:4874-4890.
129. Sullivan B.M., Juedes A., Szabo S.J., von Herrath M., Glimcher L.H. Antigen-driven effector CD8 T cell function regulated by T-bet. Proc Natl Acad Sci U S A 2003, 100:15818-15823.
130. Tacken P.J., de Vries I.J., Torensma R., Figdor C.G. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting. Nat Rev Immunol 2007, 7:790-802.
131. Takayama T., Tahara H., Thomson A.W. Differential effects of myeloid dendritic cells retrovirally transduced to express mammalian or viral interleukin-10 on cytotoxic T lymphocyte and natural killer cell functions and resistance to tumor growth. Transplantation 2001, 71:1334-1340.
132. Taniguchi R.T., Guzior D., Kumar V. 2B4 inhibits NK-cell fratricide. Blood 2007, 110:2020-2023.
133. Terme M., Chaput N., Combadiere B., Ma A., Ohteki T., Zitvogel L. Regulatory T cells control dendritic cell/NK cell cross-talk in lymph nodes at the steady state by inhibiting CD4+ self-reactive T cells. J Immunol 2008, 180:4679-4686.
134. Thapa M., Kuziel W.A., Carr D.J. Susceptibility of CCR5-deficient mice to genital herpes simplex virus type 2 is linked to NK cell mobilization. J Virol 2007, 81:3704-3713.
135. Tosi D., Valenti R., Cova A., Sovena G., Huber V., Pilla L., Arienti F., Belardelli F., Parmiani G., Rivoltini L. Role of cross-talk between IFN-alpha-induced monocyte-derived dendritic cells and NK cells in priming CD8+ T cell responses against human tumor antigens. J Immunol 2004, 172:5363-5370.
136. Townsend M.J., Weinmann A.S., Matsuda J.L., Salomon R., Farnham P.J., Biron C.A., Gapin L., Glimcher L.H. T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells. Immunity 2004, 20:477-494.
137. Trzonkowski P., Szmit E., Mysliwska J., Dobyszuk A., Mysliwski A. CD4+CD25+ T regulatory cells inhibit cytotoxic activity of T CD8+ and NK lymphocytes in the direct cell-to-cell interaction. Clin Immunol 2004, 112:258-567.
138. van den Broeke L.T., Daschbach E., Thomas E.K., Andringa G., Berzofsky J.A. Dendritic cell-induced activation of adaptive and innate antitumor immunity. J Immunol 2003, 171:5842-5852.
139. Vankayalapati R., Klucar P., Wizel B., Weis S.E., Samten B., SafiH., Shams H., Barnes P.F. NK cells regulate CD8+ T cell effector function in response to an intracellular pathogen. J Immunol 2004, 172:130-137.
140. Vignali D.A., Collison L.W., Workman C.J. How regulatory T cells work. Nat Rev Immunol 2008, 8:523-532.
141. Viret C., Janeway C.A. MHC and T cell development. Rev Immunogenet 1999, 1:91-104.
142. Vivier E., Tomasello E., Baratin M., Walzer T., Ugolini S. Functions of natural killer cells. Nat Immunol 2008, 9:503-510.
143. Vosshenrich C.A., Lesjean-Pottier S., Hasan M., Richard-Le Goff O., Corcuff E., Mandelboim O., Di Santo J.P. CD11cloB220+ interferon-producing killer dendritic cells are activated natural killer cells. J Exp Med 2007, 204:2569-2578.
144. Walker C., Checkel J., Cammisuli S., Leibson P.J., Gleich G.J. IL-5 production by NK cells contributes to eosinophil infiltration in a mouse model of allergic inflammation. J Immunol 1998, 161:1962-1969.
145. Weaver C.T., Hatton R.D., Mangan P.R., Harrington L.E. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007, 25:821-852.
146. Wendt K., Wilk E., Buyny S., Schmidt R.E., Jacobs R. Interleukin-21 differentially affects human natural killer cell subsets. Immunology 2007, 122:486-495.
147. Wilson J.L., Heffler L.C., Charo J., Scheynius A., Bejarano M.T., Ljunggren H.G. Targeting of human dendritic cells by autologous NK cells. J Immunol 1999, 163:6365-6370.
148. Wolk K., Sabat R. Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells. Cytokine Growth Factor Rev 2006, 17:367-380.
149. Yu C.R., Kirken R.A., Malabarba M.G., Young H.A., Ortaldo J.R. Differential regulation of the Janus kinase-STAT pathway and biologic function of IL-13 in primary human NK and T cells: a comparative study with IL-4. J Immunol 1998, 161:218-227.
150. Yu G., Xu X., Vu M.D., Kilpatrick E.D., Li X.C. NK cells promote transplant tolerance by killing donor antigen-presenting cells. J Exp Med 2006, 203:1851-1858.
151. Zhang D.H., Cohn L., Ray P., Bottomly K., Ray A. Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. J Biol Chem 1997, 272:21597-21603.
152. Zheng W., Flavell R.A. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 1997, 89:587-596.
153. Zhu J., Paul W.E. CD4 T cells: fates, functions, and faults. Blood 2008, 112:1557-1569.
154. Zingoni A., Sornasse T., Cocks B.G., Tanaka Y., Santoni A., Lanier L.L. Cross-talk between activated human NK cells and CD4+ T cells via OX40-OX40 ligand interactions. J Immunol 2004, 173:3716-3724.